Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Guardant Health Inc GH

Healthcare
Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer... see more

Recent & Breaking News (NDAQ:GH)

Guardant Health to Present Data Highlighting the Clinical Utility of Its Liquid Biopsy Tests in Gastrointestinal Cancers at ASCO GI Cancers Symposium

Business Wire January 19, 2022

Guardant Health Enrolls First Patient in SHIELD LUNG Study to Evaluate Accuracy of Its Blood Test to Detect Lung Cancer in High-Risk Adults

Business Wire January 18, 2022

Guardant Health and Foundation Medicine Reach Settlement in Digital Sequencing Technology Litigation

Business Wire January 7, 2022

Guardant Health to Participate Virtually in the 40th Annual J.P. Morgan Healthcare Conference

Business Wire December 29, 2021

Guardant Health Reaches Target Enrollment of 12,750 Patients in ECLIPSE Pivotal Study for its LUNAR(TM)-2 Blood Test to Detect Colorectal Cancer

Business Wire December 17, 2021

Guardant Health Presents Data Demonstrating Utility of Comprehensive Genetic Profiling with Guardant360® Liquid Biopsy Test to Guide Treatment for Advanced Breast Cancer Patients at 2021 San Antonio Breast Cancer Symposium

Business Wire December 6, 2021

Study Shows Guardant360® Liquid Biopsy Test Helps Guide Treatment for Patients with HER2-Driven Metastatic Colorectal Cancer

Business Wire November 11, 2021

Guardant Health to Participate in the 2021 Stifel Healthcare Conference

Business Wire November 8, 2021

Guardant Health Reports Third Quarter 2021 Financial Results

Business Wire November 4, 2021

Guardant Health and The Royal Marsden NHS Foundation Trust Announce Partnership to Establish First Guardant Health Liquid Biopsy Testing Service Based in the United Kingdom

Business Wire November 3, 2021

Data Presented at ACG Shows Guardant Health's Blood-Based Test Accurately Detects Early-Stage Colorectal Cancer

Business Wire October 25, 2021

Guardant Health Appoints Myrtle Potter to Its Board of Directors

Business Wire October 20, 2021

Guardant Health to Report Third Quarter Financial Results on November 4, 2021

Business Wire October 8, 2021

Guardant Health Initiates ORACLE Study to Evaluate Performance of Guardant Reveal(TM) Blood Test to Predict Recurrence Across Early-Stage Cancers

Business Wire October 5, 2021

Guardant Health Showcases Data at ESMO 2021 Demonstrating Utility of Guardant360® Liquid Biopsy to Obtain Comprehensive Molecular Information to Guide Targeted Therapy Options for Late-Stage Cancers

Business Wire September 15, 2021

New Data at IASLC 2021 World Conference on Lung Cancer Demonstrates Advantages of Using the Guardant360® Liquid Biopsy Blood Test for Comprehensive Genomic Profiling in Advanced Lung Cancer

GlobeNewswire September 7, 2021

Guardant Health to Participate in the Morgan Stanley Global Healthcare Conference

GlobeNewswire September 2, 2021

Guardant Health to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit

Business Wire August 6, 2021

Guardant Health Announces New Leadership Structure Aligned with Strategic Growth Objectives and Expands Board of Directors

Business Wire August 5, 2021

Guardant Health Reports Second Quarter 2021 Financial Results

Business Wire August 5, 2021